Evidence map›Paper›PMID 42352480›Full record

ArticleCancers2026

Radiotherapy for Ductal Carcinoma In Situ: Toxicity, Quality of Life, and Decisional Regret at a Tertiary Cancer Center.

Husam Abdulsattar Alhasan, Markus Anton Schirmer, Leif Hendrik Dröge, Carla Marie Zwerenz, Manuel Guhlich, Sandra Donath, Stefan Rieken, Gunther Felmerer, Stephanie Bendrich

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Husam Abdulsattar AlhasanDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0009-0001-9022-6411
Markus Anton SchirmerDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.
Leif Hendrik DrögeDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0000-0002-5378-4246
Carla Marie ZwerenzDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0009-0001-9620-8601
Manuel GuhlichDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0000-0002-2599-6196
Sandra DonathDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.
Stefan RiekenDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0009-0000-7018-2856
Gunther FelmererComprehensive Cancer Center Göttingen (G-CCC), University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0000-0002-0935-1208
Stephanie BendrichDepartment of Radiation Oncology, University Medical Center Goettingen (UMG), Robert-Koch-Str. 40, 37075 Goettingen, Germany.ORCID 0009-0001-6562-6616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant radiotherapydecisional regretductal carcinoma in situlong term toxicityquality of liferecurrencerisk factors

Identifiers

PMID42352480
PMCPMC13297482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.